The Great Western Chorus of Bristol. In 2010, NY1 was the defendant against one of its former employees, who sued the station. Ramsay was called to the stand as a witness during the trial, which dated back to his time of employment at NY1. NY1 prevailed in the suit as the jury rejected all the allegations. Gary Anthony Ramsay Gary Anthony Ramsay is an American news anchor, journalist, diversity advocate and communications businessman. He worked with WCTQ and WINK-TV, before spending 15 years as an anchor with NY1 from 1992 onwards. In 2007, Ramsay left his role with NY1 to launch his own media company 	Gary Anthony Ramsay
8684653	Duke University Human Vaccine Institute Duke University Human Vaccine Institute In 1990, the Duke Human Vaccine Institute (DHVI), located in Durham, North Carolina, was formed to support interdisciplinary efforts across Duke University School of Medicine to develop vaccines and therapeutics for HIV and other emerging infections that threaten the health of people living in the United States and the world. Since 1990, DHVI investigators have been at the forefront in the battle against AIDS and specifically in the quest for an HIV vaccine. In 2002, DHVI received support from the Dean of the School of Medicine to recruit new faculty for HIV research and to 	Duke University Human Vaccine Institute
8684654	apply for a Regional Center for Excellence in Emerging Infections and Biodefense grant from the National Institutes of Health (NIH). In 2003, the NIH funded the construction of the Duke Global Health Research Building, an infectious disease research facility and a Regional Biocontainment Laboratory (RBL). Completed in 2006, this building is designed to support basic research necessary to develop drugs, diagnostics, and vaccines for emerging infections and biodefense, and to provide surge capacity in the event of a public health emergency. In 2005, DHVI became the home to the NIAID funded Center for HIV/AIDS Vaccine Immunology, a $350	Duke University Human Vaccine Institute
8684655	M grant to speed the development of an AIDS vaccine. Led by Barton Haynes, MD this effort has had a major effect on the progress of the entire field of HIV vaccine development, and has pointed the way to new progress. A recent example of this DHVI-led progress has been the leadership of the DHVI in the immune correlates analysis of the RV144 vaccine trial. RV144 showed an estimated vaccine efficacy of 31.2%, and the study of the correlates of immunity is a critical opportunity for the field to understand why this trial worked, in order to make future 	Duke University Human Vaccine Institute
8684656	vaccines perform better. Over the next 7 years (beginning in 2012), the Duke CHAVI-ID will build on the progress that was made by the CHAVI consortium and apply state-of-the-art technologies and both immunologic and virologic tools to improve rational HIV-1 vaccine design. The vaccine strategy of the Duke CHAVI-ID is based on identifying and targeting novel HIV-1 vulnerabilities to B, T and NK cell immune responses and using this information to design vaccines that will induce protective immunity at the time and location of HIV-1 transmission. The Duke Human Vaccine Institute has now established a 	Duke University Human Vaccine Institute
8684657	place of national and international leadership in the fight against major infectious diseases such as HIV, TB and influenza. References. https://web.archive.org/web/20150626132513/http://dhvi.duke.edu/about-institute http://chavi-id-duke.org/about-us Duke University Human Vaccine Institute In 1990, the Duke Human Vaccine Institute (DHVI), located in Durham, North Carolina, was formed to support interdisciplinary efforts across Duke University School of Medicine to develop vaccines and therapeutics for HIV and other emerging infections that threaten the health of people living in the United States and the world. Since 1990, DHVI investigators have been at the forefront in the battle against AIDS and specifically in the quest for an HIV vaccine	Duke University Human Vaccine Institute
8684658	The Great Western Chorus of Bristol The Great Western Chorus of Bristol The Great Western Chorus of Bristol (formerly Great Western Chorus of the Bristol Barbershop Harmony Club, also formerly Western Gateway Chorus, also known as GWC) is a men's a cappella chorus singing primarily in the Barbershop style. It is a founder member of the British Association of Barbershop Singers, with whom the chorus shared its 40th anniversary in 2014. The Great Western Chorus is the most successful chorus in the association. History. The Great Western Chorus of Bristol was founded in 1974, following a visit by American Barbershop singers to the city. Competitions	The Great Western Chorus of Bristol
8684659	. The chorus holds the record for the most gold medals awarded in the BABS national chorus contest, winning for the tenth time in May 2017. In addition to being winners of a record ten BABS gold medals (1977, 1980, 1981, 1983, 1988, 1990, 2008, 2010, 2015 and 2017), the chorus are four times BABS silver medalists and five times bronze medallists and hold more chorus competition medals than any other chorus in the association. They have also always placed within the top five nationally. The chorus was Radio 3 Choir of the Year" 2006 finalists and won the men's  choir class of the inaugural Barnardo's Adult Choir Competition in 2013. The Great Western Chorus of Bristol The Great Western Chorus of Bristol (formerly Great Western Chorus of the Bristol Barbershop Harmony Club, also formerly Western Gateway Chorus, also known as GWC) is a men's a cappella chorus singing primarily in the Barbershop style. It is a founder member of the British Association of Barbershop Singers, with whom the chorus shared its 40th anniversary in 2014. The Great Western Chorus is the most successful chorus in the association. History. The Great Western Chorus of Bristol was founded in